Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. Academic Article

abstract

• This review summarizes a series of studies demonstrating that heparan sulfate proteoglycans act to promote the growth and metastasis of myeloma and breast tumors, two tumors that home to, and grow within, bone. Much of the growth-promoting effect of proteoglycans in these tumors may reside in the shed form of syndecan-1 that acts to favorably condition the tumor microenvironment. Moreover, the interplay between heparan sulfate and the extracellular enzyme heparanase-1 also has important regulatory implications. Recent studies indicate that the activity of heparanase, which likely releases heparin sulfate-bound growth factors and generates highly active heparan sulfate fragments, also promotes growth and metastasis of myeloma and breast tumors. Understanding the role of heparan sulfate and heparanase in the regulation of tumor behavior may lead to new therapeutic approaches for treating cancer.

authors

• Suva, Larry

published proceedings

• Matrix Biol

altmetric score

• 3

author list (cited authors)

• Sanderson, R. D., Yang, Y., Suva, L. J., & Kelly, T.

citation count

• 171

complete list of authors

• Sanderson, Ralph D||Yang, Yang||Suva, Larry J||Kelly, Thomas

publication date

• October 2004

publisher

• Elsevier  Publisher

published in

• Matrix Biol  Journal

keywords

• Animals
• Bone Neoplasms
• Breast Neoplasms
• Cell Proliferation
• Glucuronidase
• Heparan Sulfate Proteoglycans
• Heparitin Sulfate
• Humans
• Models, Biological
• Multiple Myeloma
• Neoplasm Metastasis
• Osteolysis

PubMed Central ID

• 15533755

Digital Object Identifier (DOI)

• 10.1016/j.matbio.2004.08.004

start page

• 341

end page

• 352

volume

• 23

issue

• 6

URL

• http://dx.doi.org/10.1016/j.matbio.2004.08.004